| 5HV | 表記: | N-[2-(diethylamino)ethyl]-2-{2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}-N-{[
4'-(trifluoromethyl)biphenyl-4-yl]methyl}acetamide | 組成式: | C36 H38 F4 N4 O2 S | SMILES: | CCN(CC)CCN(Cc2ccc(c1ccc(C(F)(F)F)cc1)cc2)C(=O)CN3C(=NC(C4=C3CCC4)=O)SCc5ccc(cc5)F | InChi: | InChI=1S/C36H38F4N4O2S/c1-3-42(4-2)20-21-43(22-25-8-12-27(13-9-25)28-14-16-29(17-15-28)36(38,39)40)33(45)23-44-32-7-5-6-31(32)34(46)41-35(44)47-24-26-10-18-30(37)19-11-26/h8-19H,3-7,20-24H2,1-2H3 | 別名: | Darapladib | 定義日: | 2015-09-28 | 最終更新日: | 2020-06-17 | 公開日: | 2016-06-15 | 識別子(ID): | N-[2-(diethylamino)ethyl]-2-{2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}-N-{[4'-(trifluoromethyl)biphenyl-4-yl]methyl}acetamide |
|
| 5I5 | 表記: | 7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE | 組成式: | C11 H13 I N4 O3 | SMILES: | Ic2c1c(ncnc1n(c2)C3OC(C(O)C3O)C)N | InChi: | InChI=1S/C11H13IN4O3/c1-4-7(17)8(18)11(19-4)16-2-5(12)6-9(13)14-3-15-10(6)16/h2-4,7-8,11,17-18H,1H3,(H2,13,14,15)/t4-,7-,8-,11-/m1/s1 | 別名: | 5'-DEOXY-5-IODOTUBERCIDIN | 定義日: | 2006-10-20 | 最終更新日: | 2020-06-17 | 識別子(ID): | 7-(5-deoxy-beta-D-ribofuranosyl)-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
|
| 5ID | 表記: | (2R,3R,4S,5R)-2-(4-AMINO-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL | 組成式: | C11 H13 I N4 O4 | SMILES: | Ic2c1c(ncnc1n(c2)C3OC(C(O)C3O)CO)N | InChi: | InChI=1S/C11H13IN4O4/c12-4-1-16(10-6(4)9(13)14-3-15-10)11-8(19)7(18)5(2-17)20-11/h1,3,5,7-8,11,17-19H,2H2,(H2,13,14,15)/t5-,7-,8-,11-/m1/s1 | 別名: | 5-IODOTUBERCIDIN | 定義日: | 2005-10-16 | 最終更新日: | 2020-06-17 | 識別子(ID): | 5-iodo-7-beta-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
|
| M30 | 表記: | N-cyclohexylglycine | 組成式: | C8 H15 N O2 | SMILES: | O=C(O)CNC1CCCCC1 | InChi: | InChI=1S/C8H15NO2/c10-8(11)6-9-7-4-2-1-3-5-7/h7,9H,1-6H2,(H,10,11) | 別名: | (2S)-1-[cyclohexylamino)acetyl-N-{4-[amino(imino)methyl]benzyl}pyrrolidine-2-carboxamide | 定義日: | 2011-02-17 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-cyclohexylglycine |
|
| 5J6 | 表記: | methyl 4-(2-bromo-4-fluorophenyl)-6-(morpholin-4-ylmethyl)-2-(1,3-thiazol-2-yl)pyrimidine-5-carboxylate | 組成式: | C20 H18 Br F N4 O3 S | SMILES: | Fc1cc(Br)c(cc1)c3nc(c2sccn2)nc(c3C(OC)=O)CN4CCOCC4 | InChi: | InChI=1S/C20H18BrFN4O3S/c1-28-20(27)16-15(11-26-5-7-29-8-6-26)24-18(19-23-4-9-30-19)25-17(16)13-3-2-12(22)10-14(13)21/h2-4,9-10H,5-8,11H2,1H3 | 別名: | NVR10-001E2 | 定義日: | 2015-09-29 | 最終更新日: | 2020-06-17 | 公開日: | 2015-12-09 | 識別子(ID): | methyl 4-(2-bromo-4-fluorophenyl)-6-(morpholin-4-ylmethyl)-2-(1,3-thiazol-2-yl)pyrimidine-5-carboxylate |
|
| 5JK | 表記: | 7alpha-hydroxycholesterol | 組成式: | C27 H46 O2 | SMILES: | CC34CCC2C1(CCC(O)CC1=CC(C2C3CCC4C(C)CCCC(C)C)O)C | InChi: | InChI=1S/C27H46O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h16-18,20-25,28-29H,6-15H2,1-5H3/t18-,20+,21-,22+,23+,24-,25+,26+,27-/m1/s1 | 別名: | (3beta,7alpha,9beta,14beta)-cholest-5-ene-3,7-diol | 定義日: | 2015-10-02 | 最終更新日: | 2020-06-17 | 公開日: | 2016-04-13 | 識別子(ID): | (3beta,7alpha,9beta,14beta)-cholest-5-ene-3,7-diol |
|
| 5JO | 表記: | 2'-O-prop-2-yn-1-yladenosine 5'-(dihydrogen phosphate) | 組成式: | C13 H16 N5 O7 P | SMILES: | O(CC1C(O)C(OCC#C)C(O1)n2c3c(nc2)c(N)ncn3)P(O)(O)=O | InChi: | InChI=1S/C13H16N5O7P/c1-2-3-23-10-9(19)7(4-24-26(20,21)22)25-13(10)18-6-17-8-11(14)15-5-16-12(8)18/h1,5-7,9-10,13,19H,3-4H2,(H2,14,15,16)(H2,20,21,22)/t7-,9-,10-,13-/m1/s1 | 別名: | 2'-Propargyl-Adenosine | 定義日: | 2015-10-02 | 最終更新日: | 2020-06-17 | 公開日: | 2015-12-02 | 識別子(ID): | 2'-O-prop-2-yn-1-yladenosine 5'-(dihydrogen phosphate) |
|
| M4Y | 表記: | parthenolide | 組成式: | C15 H20 O3 | SMILES: | C1(=C)C(=O)OC2C3C(C)(CCC=C(C)CCC12)O3 | InChi: | InChI=1S/C15H20O3/c1-9-5-4-8-15(3)13(18-15)12-11(7-6-9)10(2)14(16)17-12/h5,11-13H,2,4,6-8H2,1,3H3/b9-5+/t11-,12-,13+,15+/m0/s1 | 別名: | (1aR,4E,7aS,10aS,10bR)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1
aH)-one | 定義日: | 2019-03-25 | 最終更新日: | 2020-06-17 | 公開日: | 2019-06-26 | 識別子(ID): | (1aR,4E,7aS,10aS,10bR)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one |
|
| 5KO | 表記: | (3R)-3-hydroxybutanal | 組成式: | C4 H8 O2 | SMILES: | O=CCC(C)O | InChi: | InChI=1S/C4H8O2/c1-4(6)2-3-5/h3-4,6H,2H2,1H3/t4-/m1/s1 | 別名: | Faropenem adduct | 定義日: | 2015-10-13 | 最終更新日: | 2020-06-17 | 公開日: | 2016-10-26 | 識別子(ID): | (3R)-3-hydroxybutanal |
|
| M51 | 表記: | {(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-yl}(1,3-thiazolidin-3-yl)methanone | 組成式: | C22 H30 N6 O S | SMILES: | O=C(N1CCSC1)C5NCC(N4CCN(c3cc(nn3c2ccccc2)C)CC4)C5 | InChi: | InChI=1S/C22H30N6OS/c1-17-13-21(28(24-17)18-5-3-2-4-6-18)26-9-7-25(8-10-26)19-14-20(23-15-19)22(29)27-11-12-30-16-27/h2-6,13,19-20,23H,7-12,14-16H2,1H3/t19-,20-/m0/s1 | 別名: | Teneligliptin | 定義日: | 2011-11-08 | 最終更新日: | 2020-06-17 | 公開日: | 2012-10-19 | 識別子(ID): | {(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-yl}(1,3-thiazolidin-3-yl)methanone |
|
| 5KY | 表記: | 2-({[2-amino-4-(trifluoromethyl)phenyl]carbamoyl}amino)-4-methylbenzoic acid | 組成式: | C16 H14 F3 N3 O3 | SMILES: | c1(c(cc(cc1)C)NC(=O)Nc2ccc(C(F)(F)F)cc2N)C(O)=O | InChi: | InChI=1S/C16H14F3N3O3/c1-8-2-4-10(14(23)24)13(6-8)22-15(25)21-12-5-3-9(7-11(12)20)16(17,18)19/h2-7H,20H2,1H3,(H,23,24)(H2,21,22,25) | 別名: | BF174 | 定義日: | 2015-10-15 | 最終更新日: | 2020-06-17 | 公開日: | 2016-10-26 | 識別子(ID): | 2-({[2-amino-4-(trifluoromethyl)phenyl]carbamoyl}amino)-4-methylbenzoic acid |
|
| 5L8 | 表記: | (2~{R})-2-(1-chloranylcyclopropyl)-1-(2-chlorophenyl)-3-(1,2,4-triazol-1-yl)propan-2-ol | 組成式: | C14 H15 Cl2 N3 O | SMILES: | O[C](Cn1cncn1)(Cc2ccccc2Cl)C3(Cl)CC3 | InChi: | InChI=1S/C14H15Cl2N3O/c15-12-4-2-1-3-11(12)7-14(20,13(16)5-6-13)8-19-10-17-9-18-19/h1-4,9-10,20H,5-8H2/t14-/m1/s1 | 別名: | R-desthio-prothioconazole | 定義日: | 2015-10-19 | 最終更新日: | 2020-06-17 | 公開日: | 2016-02-10 | 識別子(ID): | (2~{R})-2-(1-chloranylcyclopropyl)-1-(2-chlorophenyl)-3-(1,2,4-triazol-1-yl)propan-2-ol |
|
| 5LN | 表記: | chloranyl-bis(hydroxymethyl)-bis(oxidanyl)ruthenium | 組成式: | C2 H8 Cl O4 Ru | SMILES: | OC[Ru](O)(O)(Cl)CO | InChi: | InChI=1S/2CH3O.ClH.2H2O.Ru/c2*1-2 | 別名: | Ru(CO)2Cl(OH2)2 | 定義日: | 2015-10-20 | 最終更新日: | 2020-06-17 | 公開日: | 2016-10-26 | 識別子(ID): | chloranyl-bis(hydroxymethyl)-bis(oxidanyl)ruthenium |
|
| 5LU | 表記: | Prochloraz | 組成式: | C15 H16 Cl3 N3 O2 | SMILES: | CCCN(CCOc1c(Cl)cc(Cl)cc1Cl)C(=O)n2ccnc2 | InChi: | InChI=1S/C15H16Cl3N3O2/c1-2-4-20(15(22)21-5-3-19-10-21)6-7-23-14-12(17)8-11(16)9-13(14)18/h3,5,8-10H,2,4,6-7H2,1H3 | 別名: | ~{N}-propyl-~{N}-[2-[2,4,6-tris(chloranyl)phenoxy]ethyl]imidazole-1-carboxamide | 定義日: | 2015-10-21 | 最終更新日: | 2020-06-17 | 公開日: | 2016-02-10 | 識別子(ID): | ~{N}-propyl-~{N}-[2-[2,4,6-tris(chloranyl)phenoxy]ethyl]imidazole-1-carboxamide |
|
| 5LW | 表記: | 1-[[(2~{S},4~{S})-2-[2-chloranyl-4-(4-chloranylphenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]-1,2,4-triazole | 組成式: | C19 H17 Cl2 N3 O3 | SMILES: | C[CH]1CO[C](Cn2cncn2)(O1)c3ccc(Oc4ccc(Cl)cc4)cc3Cl | InChi: | InChI=1S/C19H17Cl2N3O3/c1-13-9-25-19(27-13,10-24-12-22-11-23-24)17-7-6-16(8-18(17)21)26-15-4-2-14(20)3-5-15/h2-8,11-13H,9-10H2,1H3/t13-,19+/m0/s1 | 別名: | Difenoconazole | 定義日: | 2015-10-21 | 最終更新日: | 2020-06-17 | 公開日: | 2016-02-10 | 識別子(ID): | 1-[[(2~{S},4~{S})-2-[2-chloranyl-4-(4-chloranylphenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]-1,2,4-triazole |
|
| 5LX | 表記: | 1-[[(2~{R},4~{S})-2-[2-chloranyl-4-(4-chloranylphenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]-1,2,4-triazole | 組成式: | C19 H17 Cl2 N3 O3 | SMILES: | C[CH]1CO[C](Cn2cncn2)(O1)c3ccc(Oc4ccc(Cl)cc4)cc3Cl | InChi: | InChI=1S/C19H17Cl2N3O3/c1-13-9-25-19(27-13,10-24-12-22-11-23-24)17-7-6-16(8-18(17)21)26-15-4-2-14(20)3-5-15/h2-8,11-13H,9-10H2,1H3/t13-,19-/m0/s1 | 別名: | Difenoconazole | 定義日: | 2015-10-21 | 最終更新日: | 2020-06-17 | 公開日: | 2016-02-10 | 識別子(ID): | 1-[[(2~{R},4~{S})-2-[2-chloranyl-4-(4-chloranylphenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]-1,2,4-triazole |
|
| DLW | 表記: | (5~{S})-2-[(~{E})-~{N}-(2-ethoxyphenyl)-~{C}-methyl-carbonimidoyl]-3-oxidanyl-5-phenyl-cyclohex-2-en-1-one | 組成式: | C22 H23 N O3 | SMILES: | CCOc1ccccc1N=C(C)C2=C(O)C[CH](CC2=O)c3ccccc3 | InChi: | InChI=1S/C22H23NO3/c1-3-26-21-12-8-7-11-18(21)23-15(2)22-19(24)13-17(14-20(22)25)16-9-5-4-6-10-16/h4-12,17,24H,3,13-14H2,1-2H3/b23-15+/t17-/m0/s1 | 別名: | KNI-10075 | 定義日: | 2018-01-24 | 最終更新日: | 2020-06-17 | 公開日: | 2018-03-21 | 識別子(ID): | (5~{S})-2-[(~{E})-~{N}-(2-ethoxyphenyl)-~{C}-methyl-carbonimidoyl]-3-oxidanyl-5-phenyl-cyclohex-2-en-1-one |
|
| DLZ | 表記: | 1-deoxy-1-(6,7-dimethyl-2,4-dioxo-3,4-dihydropteridin-8(2H)-yl)-D-ribitol | 組成式: | C13 H18 N4 O6 | SMILES: | O=C2N=C1N(C(=C(N=C1C(=O)N2)C)C)CC(O)C(O)C(O)CO | InChi: | InChI=1S/C13H18N4O6/c1-5-6(2)17(3-7(19)10(21)8(20)4-18)11-9(14-5)12(22)16-13(23)15-11/h7-8,10,18-21H,3-4H2,1-2H3,(H,16,22,23)/t7-,8+,10-/m0/s1 | 別名: | 6,7-dimethyl-8-(1'-D-ribityl) lumazine | 定義日: | 2009-06-16 | 最終更新日: | 2020-06-17 | 識別子(ID): | 1-deoxy-1-(6,7-dimethyl-2,4-dioxo-3,4-dihydropteridin-8(2H)-yl)-D-ribitol |
|
| DM1 | 表記: | DAUNOMYCIN | 組成式: | C27 H29 N O10 | SMILES: | O=C2c1c(O)c5c(c(O)c1C(=O)c3cccc(OC)c23)CC(O)(C(=O)C)CC5OC4OC(C(O)C(N)C4)C | InChi: | InChI=1S/C27H29NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3/t10-,14-,16-,17-,22+,27-/m0/s1 | 別名: | DAUNORUBICIN | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside |
|
| DM5 | 表記: | IDARUBICIN | 組成式: | C26 H27 N O9 | SMILES: | O=C2c1c(O)c5c(c(O)c1C(=O)c3ccccc23)CC(O)(C(=O)C)CC5OC4OC(C(O)C(N)C4)C | InChi: | InChI=1S/C26H27NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3/t10-,15-,16-,17-,21+,26-/m0/s1 | 別名: | 4-DEMETHOXY-DAUNORUBICIN | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside |
|
| DM7 | 表記: | 4'-DEOXY-4'-IODODOXORUBICIN | 組成式: | C27 H29 I N O10 | SMILES: | O=C2c1c(O)c5c(c(O)c1C(=O)c3cccc(OC)c23)CC(O)(C(=O)CO)CC5OC4OC(C(I)C(C4)[NH3+])C | InChi: | InChI=1S/C27H28INO10/c1-10-22(28)13(29)6-17(38-10)39-15-8-27(36,16(31)9-30)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,30,33,35-36H,6-9,29H2,1-2H3/p+1/t10-,13-,15-,17-,22+,27-/m0/s1 | 別名: | 4'-DEOXY-4'-IODOADRIAMYCIN | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2S,3S,4S,6R)-3-iodo-2-methyl-6-{[(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl]oxy}tetrahydro-2H-pyran-4-aminium |
|
| DM8 | 表記: | 2'-BROMO-4'-EPIDAUNORUBICIN | 組成式: | C27 H28 Br N O10 | SMILES: | O=C2c1c(O)c5c(c(O)c1C(=O)c3cccc(OC)c23)CC(O)(C(=O)C)CC5OC4OC(C(O)C(N)C4Br)C | InChi: | InChI=1S/C27H28BrNO10/c1-9-21(31)20(29)19(28)26(38-9)39-14-8-27(36,10(2)30)7-12-16(14)25(35)18-17(23(12)33)22(32)11-5-4-6-13(37-3)15(11)24(18)34/h4-6,9,14,19-21,26,31,33,35-36H,7-8,29H2,1-3H3/t9-,14-,19+,20-,21-,26-,27-/m0/s1 | 別名: | WP401 | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2-bromo-2,3,6-trideoxy-alpha-L-mannopyranoside |
|
| DMP | 表記: | [4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-[1,3-BIS([4-HYDROXYMETHYL-PHENYL]METHYL)-4,7-BIS(PHEN
YLMETHYL)]-2H-1,3-DIAZEPINONE | 組成式: | C35 H38 N2 O5 | SMILES: | O=C1N(C(C(O)C(O)C(N1Cc2ccc(cc2)CO)Cc3ccccc3)Cc4ccccc4)Cc5ccc(cc5)CO | InChi: | InChI=1S/C35H38N2O5/c38-23-29-15-11-27(12-16-29)21-36-31(19-25-7-3-1-4-8-25)33(40)34(41)32(20-26-9-5-2-6-10-26)37(35(36)42)22-28-13-17-30(24-39)18-14-28/h1-18,31-34,38-41H,19-24H2/t31-,32-,33+,34+/m1/s1 | 別名: | DMP323(INHIBITOR OF DUPONT MERCK) | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | (4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[4-(hydroxymethyl)benzyl]-1,3-diazepan-2-one |
|
| DMY | 表記: | DISTAMYCIN A | 組成式: | C22 H27 N9 O4 | SMILES: | O=C(Nc1cc(C(=O)NCCC(=[N@H])N)n(c1)C)c3cc(NC(=O)c2cc(NC=O)cn2C)cn3C | InChi: | InChI=1S/C22H27N9O4/c1-29-9-13(26-12-32)6-17(29)21(34)28-15-8-18(31(3)11-15)22(35)27-14-7-16(30(2)10-14)20(33)25-5-4-19(23)24/h6-12H,4-5H2,1-3H3,(H3,23,24)(H,25,33)(H,26,32)(H,27,35)(H,28,34) | 別名: | DISTAMYCIN | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-[5-({5-[(3-amino-3-iminopropyl)carbamoyl]-1-methyl-1H-pyrrol-3-yl}carbamoyl)-1-methyl-1H-pyrrol-3-yl]-4-(formylamino)-1-methyl-1H-pyrrole-2-carboxamide |
|
| DN1 | 表記: | 3-({(2S)-2-[({(1R)-1-[({(1R)-1-[(R)-CARBOXY(HYDROXY)METHYL]-3,3-DIFLUOROPROPYL}AMINO)CARBONYL]-3-METHYLBUTYL}AMINO)CARB
ONYL]-2,3-DIHYDRO-1H-INDOL-2-YL}METHYL)THIOPHENE-2-CARBOXYLIC ACID | 組成式: | C26 H31 F2 N3 O7 S | SMILES: | O=C(O)C(O)C(NC(=O)C(NC(=O)C2(Nc1ccccc1C2)Cc3c(scc3)C(=O)O)CC(C)C)CC(F)F | InChi: | InChI=1S/C26H31F2N3O7S/c1-13(2)9-18(22(33)29-17(10-19(27)28)20(32)23(34)35)30-25(38)26(11-14-5-3-4-6-16(14)31-26)12-15-7-8-39-21(15)24(36)37/h3-8,13,17-20,31-32H,9-12H2,1-2H3,(H,29,33)(H,30,38)(H,34,35)(H,36,37)/t17-,18-,20-,26+/m1/s1 | 別名: | PEPTIDOMIMETIC INHIBITOR | 定義日: | 2004-07-14 | 最終更新日: | 2020-06-17 | 識別子(ID): | 3-{[N-({(2S)-2-[(2-carboxythiophen-3-yl)methyl]-2,3-dihydro-1H-indol-2-yl}carbonyl)-D-leucyl]amino}-3,4,5-trideoxy-5,5-difluoro-D-erythro-pentonic acid |
|